Impairment of the protein C anticoagulation pathway is critical to the thrombosis associated with sepsis and to the development of purpura fulminans in meningococcemia. We studied the expression ...

The latest expert consensus decision pathway from the American College of Cardiology tackles tricky decisions surrounding the periprocedural management of anticoagulation in patients with nonvalvular ...

June 7, 2012 (Lisbon, Portugal) — British researchers have reduced by more than half the door-to-needle time to reverse oral anticoagulant therapy (OAT) for patients with intracerebral ...

Cadrenal Therapeutics Highlights New Research on Anticoagulation Burden for LVAD Patients. ... Tecarfarin, with its novel metabolic pathway, ...

Coagulation factor Xa is targeted by a new generation of antithrombotic drugs such as rivaroxaban. However, as excessive factor Xa inhibition can cause bleeding, the clinical use of factor Xa ...

and tissue pathway factor inhibitor. The pharmacist's role in managing anticoagulation therapy in the inpatient setting has also been established. An evaluation of over 700 000 Medicare patients ...

The pathway, which applies to both vitamin K antagonists and non-vitamin K antagonist oral anticoagulants (NOACs), takes clinicians from the assessment of bleed severity to acute medical and surgical ...

A new document for the management of patients with irregular heartbeats who are on anticoagulation medications--blood thinners--and need surgery, focuses on how and when to temporarily stop these ...

(HealthDay)—A decision pathway has been developed to guide management of acute bleeding in patients treated with oral anticoagulants (OACs); the decision pathway was published online Dec. 1 in ...

A new document for the management of patients with irregular heartbeats who are on anticoagulation medications—blood thinners—and need surgery, focuses on how and when to temporarily stop ...